Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pavlina Richtrova

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Artificial Organs|July 15, 2010
Evaluation of three different methods to prevent dialyzer clotting without causing systemic anticoagulation effectPavlina Richtrova, Kamila Rulcova, Jan Mares, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|June 29, 2007
The AN69 ST haemodialysis membrane under conditions of two different extracorporeal circuit rinse protocols a comparison of thrombogenicity parametersPavlina Richtrova, Karel Opatrny, Ladislav Vit, et al.
BMC Nephrology|January 29, 2021
Substitution of citrate with tissue plasminogen activator (rt-PA) for catheter lock does not improve patency of tunnelled haemodialysis catheters in a randomised trialPavlina Richtrova, Jan Mares, Lukas Kielberger, et al.
Artificial Organs|November 19, 2016
Citrate-Buffered Dialysis Solution (Citrasate) Allows Avoidance of Anticoagulation During Intermittent Hemodiafiltration-At the Cost of Decreased Performance and Systemic BiocompatibilityPavlina Richtrova, Jan Mares, Lukas Kielberger, et al.
Proteomics. Clinical Applications|December 8, 2010
Proteomic profiling of blood-dialyzer interactome reveals involvement of lectin complement pathway in hemodialysis-induced inflammatory responseJan Mares, Pavlina Richtrova, Alena Hricinova, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Artificial Organs|July 15, 2010
Evaluation of three different methods to prevent dialyzer clotting without causing systemic anticoagulation effectPavlina Richtrova, Kamila Rulcova, Jan Mares, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|June 29, 2007
The AN69 ST haemodialysis membrane under conditions of two different extracorporeal circuit rinse protocols a comparison of thrombogenicity parametersPavlina Richtrova, Karel Opatrny, Ladislav Vit, et al.
BMC Nephrology|January 29, 2021
Substitution of citrate with tissue plasminogen activator (rt-PA) for catheter lock does not improve patency of tunnelled haemodialysis catheters in a randomised trialPavlina Richtrova, Jan Mares, Lukas Kielberger, et al.
Artificial Organs|November 19, 2016
Citrate-Buffered Dialysis Solution (Citrasate) Allows Avoidance of Anticoagulation During Intermittent Hemodiafiltration-At the Cost of Decreased Performance and Systemic BiocompatibilityPavlina Richtrova, Jan Mares, Lukas Kielberger, et al.
Proteomics. Clinical Applications|December 8, 2010
Proteomic profiling of blood-dialyzer interactome reveals involvement of lectin complement pathway in hemodialysis-induced inflammatory responseJan Mares, Pavlina Richtrova, Alena Hricinova, et al.
Pageof 1